Aude Ouensanga joined Alira Health’s Paris office in 2012 and has worked out of the Boston office since 2015. In that time, Aude has managed dozens of market access, commercial due diligence, corporate strategy and M&A projects for US, EU and Japan-based clients in MedTech and Pharma. She advises both start-ups and multi-billion dollar global corporations in their business development.
Prior to joining Alira Health, Aude worked as an M&A Analyst at BNP Paribas Corporate & Investment Banking for the chemicals sector and as a Strategy Analyst at Novartis Pharma.
Aude holds a degree from French Grande Ecole EM Lyon Business School where she specialized in Finance and Strategy and is a registered investment banker in the US, holding FINRA Series 79 and 63 certifications.